Registries and claims data are two of the most trusted sources for tracking drug safety after approval. Learn how they work, their strengths and limits, and why regulators are relying on them more than ever.
Learn why dextromethorphan and MAOI antidepressants clash, how to spot serotonin syndrome, and safe cough‑relief alternatives for patients on monoamine oxidase inhibitors.